Company / Interest Expense per Share
TherapeuticsMD, Inc. Interest Expense per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.01
FY2024
5-year range
$0.01 / $3.83
FY2020-FY2024
Trend
-31.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $3.83 to $0.01 over the past 2 years.
Based on SEC 10-K filings.
0.01 in FY2024 with a 5-year CAGR of -5.8%.
Improved from $3.83 to $0.01 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -37.1%
- 5-Year CAGR
- -5.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, interest expense per share decreased 31.4% year-over-year.
- Peak interest expense per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.01 | -31.4% |
| FY2023 | $0.02 | -99.4% |
| FY2022 | $3.83 | +6502.4% |
| FY2021 | $0.06 | +236.1% |
| FY2020 | $0.02 | -11.3% |
| FY2019 | $0.02 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026